✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Common Name
Da Ren Tang
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3,890
Ticker
600329
Exchange
SHANGHAI STOCK EXCHANGE
Description
Tianjin Pharmaceutical Da Ren Tang Co., Ltd. is a prominent player in the pharmaceuticals industry, primarily focused on the production and distribution of traditional Chinese medicine (TCM) products....

Da Ren Tang's GHG Emissions Data Preview

In 2023, Da Ren Tang completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Da Ren Tang has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023
Total Scope 1
5,901.71a
Total Scope 2
Location-Based
31,489.237a
Total Scope 3
N/A
Total Scope 1 Revenue Intensity (tCO2e/$M)
5.1012a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=600329&reporting_period=2023"

Verified Sources Behind Da Ren Tang’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Da Ren Tang's Sustainability Report 2023

Insights into Da Ren Tang's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Da Ren Tang amounted to 37,390.947 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Da Ren Tang's Scope 1 Emissions Over Time

202301.5 k3 k4.5 k6 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Da Ren Tang's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Da Ren Tang were 5,901.71 metric tons of CO₂ equivalent (tCO₂e).a

What are Da Ren Tang's Scope 2 emissions?

In 2023, Da Ren Tang reported Scope 2 greenhouse gas (GHG) emissions of 31,489.237 tCO₂e using the location-based method.a

What methodology does Da Ren Tang use for Scope 2 reporting?

In 2023, Da Ren Tang reported its Scope 2 emissions using the location-based method.a

Da Ren Tang's Scope 2 Emissions Over Time

202308 k16 k24 k32 ktCO2e
  • Total Scope 2 Location-Based

Insights into Da Ren Tang’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Da Ren Tang reported Scope 1 greenhouse gas (GHG) emissions of 5,901.71 tCO₂e and total revenues of USD 1,157 millions. This translates into an emissions intensity of 5.1 tCO₂e per millions USD.a

Da Ren Tang's Scope 1 Emissions Intensity Compared to Peers

1,0005,00050,000500,0002,000,000Scope 1 Emissions (tCO2e)1002001,0005,00010,000Revenues (Millions of USD)Huadong MedicineYear: 2024Scope 1: 15,595 tCO2eRevenue: $M 5,742Scope 1 Intensity: 2.72 tCO2e/$MFosun PharmaYear: 2024Scope 1: 184,016 tCO2eRevenue: $M 5,627Scope 1 Intensity: 32.70 tCO2e/$MZhejiang NhuYear: 2024Scope 1: 765,023 tCO2eRevenue: $M 2,961Scope 1 Intensity: 258.37 tCO2e/$MYunnan Baiyao GroupYear: 2024Scope 1: 15,079 tCO2eRevenue: $M 5,485Scope 1 Intensity: 2.75 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,680Scope 1 Intensity: 7.84 tCO2e/$MJiangsu Hengrui PharmaceuticalsYear: 2024Scope 1: 8,517 tCO2eRevenue: $M 3,835Scope 1 Intensity: 2.22 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MCR Double-CraneYear: 2024Scope 1: 58,155 tCO2eRevenue: $M 1,536Scope 1 Intensity: 37.86 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MApeloa PharmaceuticalYear: 2024Scope 1: 10,400 tCO2eRevenue: $M 1,647Scope 1 Intensity: 6.31 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 930Scope 1 Intensity: 5.37 tCO2e/$MHumanwell Healthcare (Group)Year: 2024Scope 1: 19,500 tCO2eRevenue: $M 3,485Scope 1 Intensity: 5.60 tCO2e/$MBeijing Tong Ren TangYear: 2024Scope 1: 34,974 tCO2eRevenue: $M 2,548Scope 1 Intensity: 13.72 tCO2e/$MChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 864Scope 1 Intensity: 12.44 tCO2e/$MSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 262Scope 1 Intensity: 174.19 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 364Scope 1 Intensity: 148.75 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 721Scope 1 Intensity: 25.37 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$M

How does Da Ren Tang's GHG emissions intensity compare to its peers?

In 2023, Da Ren Tang reported a Scope 1 emissions intensity of 5.1 tCO₂e per millions USD. Compared to the peer group median of 25.37, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Da Ren Tang rank on GHG emissions intensity within its industry?

In 2023, Da Ren Tang ranked 4 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Da Ren Tang among the top performers, with one of the lowest emissions intensities relative to peers.a

Want Full Access to Da Ren Tang's GHG Emissions Dataset?
Start 30-Day Free Trial